Answer:
False.. the brain is part of the nervous system... thats the circulmatory sytem job..
Explanation:
<h3 />
▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄
<h3>⇝ <u>Epidermis</u> :</h3>
Protective tissues includes epidermis & cork. Epidermis is basically a simple permanent tissue, protective in function. It forms one-cell-thick covering over all the parts of plant.
<h3>⇝ <u>Characteristics of Epidermis</u> : </h3>
- Epidermis is formed of living cells, arranged in a single layer.
- In aerial parts, epidermis is covered with a waterproof and noncellular waxy covering called cuticle.
- Cells form a continuous layer, but in leaves epidermis has small openings called stomata.
- Each stoma is guarded by a pair of bean-shaped guard cells which govern opening & closing of stomatal aperture.
<h3>⇝ <u>Functions of Epidermis</u> :</h3>
- Epidermis protects the underlying tissues from mechanical injury, chemicals & infection.
- Cuticle of epidermis protects against water loss & desiccation. It checks the rate of transpiration & evaporation and prevents wilting.
- Stomata in the epidermis of leaves help in gaseous exchange during respiration & photosynthesis.
▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄▄
Answer:
25%
Explanation:
<em>The approximate proportion of G + C content in the genome of E. coli has been reported to be 50%. According to Chargaff's rule, the amount of guanine in any DNA must be approximately equal to the amount of cytosine. </em>Hence,
if G + C = 50 and G = C,
then
G = C = 25
Therefore, the approximate percentage of guanine in the genome of <em>E. coli </em>would be 25.
The post-eradication era is a period of history for which there has been no precedent whatsoever in terms of a zero base of immunity. Cessation of immunization will eventually create a population susceptible to widespread infection in the event of accidental or intentional reintroduction or re-emergence of the eradicated virus. Thus, even after immunization ceases, vaccine production must continue.
However, many currently available vaccines may not be appropriate for continued post-eradication vaccine production or reinstatement. Vaccines must be continually improved and ongoing vaccination research maintained. Other potentially useful antiviral strategies—antivirals, prophylaxis, and probiotics—must also be considered as means to strengthen the immune system and serve as adjuvant or prophylactic therapies.
In the case of polio, for example, it remains to be determined which vaccine (oral polio vaccine [OPV] or inactivated polio vaccine [IPV]), or variant thereof, should be produced in the post-eradication, post-vaccination era. A detailed plan for vaccine production will require more information on OPV-derived viral persistence and transmission, as well as continuing dialogue between public health and research communities in order to ensure that appropriate vaccination research continues.
